Aptus Capital Advisors’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-18,298
Closed -$1.42M 597
2021
Q3
$1.42M Buy
18,298
+3,358
+22% +$253K 0.04% 213
2021
Q2
$1.07M Buy
+14,940
New +$1.09M 0.03% 227
2020
Q1
Sell
-9,881
Closed -$647K 551
2019
Q4
$647K Buy
9,881
+1,631
+20% +$112K 0.05% 227
2019
Q3
$653K Sell
8,250
-2,125
-20% -$142K 0.04% 216
2019
Q2
$598K Buy
10,375
+1,625
+19% +$95.2K 0.08% 192
2019
Q1
$458K Buy
8,750
+3,750
+75% +$196K 0.08% 205
2018
Q4
$264K Buy
+5,000
New +$286K 0.07% 122

Other funds holding CONE

Aptus Capital Advisors's CONE Position: Q4 2021 in Review

Aptus Capital Advisors sold out of CyrusOne Inc Common Stock (CONE) in Q4 2021, closing a stake of 18,298 shares — an estimated $1.42M sold.

Aptus Capital Advisors first reported a position in CONE in Q4 2018 and held it in 7 quarters. The position peaked at $1.42M in Q3 2021. 469 funds tracked by Wall St. Rank hold CONE as of Q4 2021.

  • Aptus Capital Advisors reported no remaining CyrusOne Inc Common Stock position as of Q4 2021 after selling out during the quarter.
  • Aptus Capital Advisors sold 18,298 CyrusOne Inc Common Stock shares in Q4 2021, an estimated $1.42M.
  • Aptus Capital Advisors first reported a position in CyrusOne Inc Common Stock in Q4 2018 and held it in 7 quarters.
  • Aptus Capital Advisors's CyrusOne Inc Common Stock position peaked at $1.42M in Q3 2021.
  • 469 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q4 2021.

Based on Aptus Capital Advisors's 13F filing for Q4 2021, filed 2 Feb 2022.